Preventing Calpain Externalization by Reducing ABCA1 Activity with Probenecid Limits Melanoma Angiogenesis and Development
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 140 (2) , 445-454
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in CancerFrontiers in Immunology, 2018
- Exosomes derived from B16F0 melanoma cells alter the transcriptome of cytotoxic T cells that impacts mitochondrial respirationThe FEBS Journal, 2018
- Leukocyte Calpain Deficiency Reduces Angiotensin II–Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Repositioning of drugs using open-access data portal DTome: A test case with probenecid (Review)International Journal of Molecular Medicine, 2015
- Autocrine fibronectin directs matrix assembly and crosstalk between cell–matrix and cell–cell adhesion in vascular endothelial cellsJournal of Cell Science, 2010
- Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cellsMolecular Cancer, 2009
- Extracellular Calpains Increase Tubular Epithelial Cell MobilityJournal of Biological Chemistry, 2006
- Regulated secretion of macrophage migration inhibitory factor is mediated by a non‐classical pathway involving an ABC transporterFEBS Letters, 2003
- The Calpain SystemPhysiological Reviews, 2003
- Cell-associated activation of latent transforming growth factor-β by calpainJournal of Cellular Physiology, 1998